Long-acting beta-agonists reduce mortality of patients with severe and very severe chronic obstructive pulmonary disease: a propensity score matching study.
about
Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT?Effects of transdermal tulobuterol on dyspnea and respiratory function during exercise in patients with chronic obstructive pulmonary disease.Factors associated with the incidence of serious adverse events in patients admitted with COPD acute exacerbation.Efficacy of salmeterol and formoterol combination treatment in mice with chronic obstructive pulmonary disease.
P2860
Long-acting beta-agonists reduce mortality of patients with severe and very severe chronic obstructive pulmonary disease: a propensity score matching study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Long-acting beta-agonists redu ...... opensity score matching study.
@en
type
label
Long-acting beta-agonists redu ...... opensity score matching study.
@en
prefLabel
Long-acting beta-agonists redu ...... opensity score matching study.
@en
P2093
P2860
P356
P1433
P1476
Long-acting beta-agonists redu ...... opensity score matching study.
@en
P2093
Naoki Miyazawa
Naoko Kimura
Nobuyuki Horita
Ryota Kojima
Satoshi Morita
Takeshi Kaneko
Yoshiaki Ishigatsubo
P2860
P2888
P356
10.1186/1465-9921-14-62
P577
2013-06-03T00:00:00Z
P5875
P6179
1037113314